RecruitingPhase 4NCT06228456

Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Florida
Principal Investigator
Francesco Franchi, MD
Univesrsity of Florida
Intervention
Ticagrelor 60mg(drug)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
2024 – 2027

Study locations (1)

Collaborators

Scott R. MacKenzie Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06228456 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials